Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats

MLA

Juan M. Decara, et al. “Treatment with a Novel Oleic-Acid–dihydroxyamphetamine Conjugation Ameliorates Non-Alcoholic Fatty Liver Disease in Obese Zucker Rats.” Disease Models & Mechanisms, vol. 8, no. 10, Oct. 2015, pp. 1213–25. EBSCOhost, https://doi.org/10.1242/dmm.019919.

APA

Juan M. Decara, Francisco Javier Pavón, Juan Suárez, Miguel Romero-Cuevas, Elena Baixeras, Mariam Vázquez, Patricia Rivera, Ana L. Gavito, Bruno Almeida, Jesús Joglar, Rafael de la Torre, Fernando Rodríguez de Fonseca, & Antonia Serrano. (2015). Treatment with a novel oleic-acid–dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats. Disease Models & Mechanisms, 8(10), 1213–1225. https://doi.org/10.1242/dmm.019919

Chicago

Juan M. Decara, Francisco Javier Pavón, Juan Suárez, Miguel Romero-Cuevas, Elena Baixeras, Mariam Vázquez, Patricia Rivera, et al. 2015. “Treatment with a Novel Oleic-Acid–dihydroxyamphetamine Conjugation Ameliorates Non-Alcoholic Fatty Liver Disease in Obese Zucker Rats.” Disease Models & Mechanisms 8 (10): 1213–25. doi:10.1242/dmm.019919.